JP2011502521A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502521A5
JP2011502521A5 JP2010533337A JP2010533337A JP2011502521A5 JP 2011502521 A5 JP2011502521 A5 JP 2011502521A5 JP 2010533337 A JP2010533337 A JP 2010533337A JP 2010533337 A JP2010533337 A JP 2010533337A JP 2011502521 A5 JP2011502521 A5 JP 2011502521A5
Authority
JP
Japan
Prior art keywords
polypeptide
fusion polypeptide
fusion
oligomeric
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010533337A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/083190 external-priority patent/WO2009102357A2/en
Publication of JP2011502521A publication Critical patent/JP2011502521A/ja
Publication of JP2011502521A5 publication Critical patent/JP2011502521A5/ja
Pending legal-status Critical Current

Links

JP2010533337A 2007-11-12 2008-11-12 Hiv−1外被糖タンパク質オリゴマー及び使用方法 Pending JP2011502521A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98728707P 2007-11-12 2007-11-12
PCT/US2008/083190 WO2009102357A2 (en) 2007-11-12 2008-11-12 Hiv-1 envelope glycoprotein oligomer and methods of use

Publications (2)

Publication Number Publication Date
JP2011502521A JP2011502521A (ja) 2011-01-27
JP2011502521A5 true JP2011502521A5 (cg-RX-API-DMAC7.html) 2011-11-17

Family

ID=40957413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533337A Pending JP2011502521A (ja) 2007-11-12 2008-11-12 Hiv−1外被糖タンパク質オリゴマー及び使用方法

Country Status (6)

Country Link
US (1) US8597658B2 (cg-RX-API-DMAC7.html)
EP (1) EP2235065A4 (cg-RX-API-DMAC7.html)
JP (1) JP2011502521A (cg-RX-API-DMAC7.html)
AU (1) AU2008350273B2 (cg-RX-API-DMAC7.html)
CA (1) CA2705373A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009102357A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2877205A4 (en) * 2012-07-26 2016-04-06 Jackson H M Found Military Med VACCINE WITH A MULTIMED FUSION PROTEIN AND IMMUNOTHERAPY
CN109153704A (zh) * 2016-05-02 2019-01-04 斯克里普斯研究学院 与hiv-1免疫原相关的组合物和方法
AU2018366480C1 (en) * 2017-11-17 2024-02-01 Grifols Diagnostic Solutions Inc. Novel mammalian expressed human immunodeficiency virus envelope protein antigens

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292646A (en) * 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US6039957A (en) 1993-12-10 2000-03-21 United States Of America, As Represented By The Department Of Health And Human Services Oligomeric HIV-1 envelope glycoproteins
ATE435034T1 (de) * 1998-08-04 2009-07-15 Jackson H M Found Military Med Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
WO2001019958A2 (en) * 1999-09-17 2001-03-22 Dana-Farber Cancer Institute, Inc. Stabilized soluble glycoprotein trimers
WO2003077838A2 (en) 2002-03-05 2003-09-25 National Institutes Of Health Office Of Technology Transfer Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens
AU2005280004B2 (en) * 2004-08-27 2012-02-23 Institute Of Tropical Medicine Modified HIV-1 envelope proteins

Similar Documents

Publication Publication Date Title
JP7094103B2 (ja) インフルエンザウイルスワクチンおよびその使用
AU2020219803B2 (en) Nanoparticle-based influenza virus vaccines and uses thereof
RU2015100656A (ru) Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
JP2010166916A5 (cg-RX-API-DMAC7.html)
JP2011528901A5 (cg-RX-API-DMAC7.html)
MX2012011405A (es) Anticuerpo biespecifico psmaxcd3 de simple cadena especifico de especies cruzadas.
JP2010502207A5 (cg-RX-API-DMAC7.html)
JP2012501959A5 (cg-RX-API-DMAC7.html)
MX340014B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
JP2008525033A5 (cg-RX-API-DMAC7.html)
JP2012095652A5 (cg-RX-API-DMAC7.html)
PH12012500849A1 (en) Mycobacterial vaccines
NZ600348A (en) Anti-c5a binding moieties with high blocking activity
JP2015212284A5 (cg-RX-API-DMAC7.html)
UA110473C2 (uk) Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1
JP2013520487A5 (cg-RX-API-DMAC7.html)
JP2015505309A5 (cg-RX-API-DMAC7.html)
EP2292647A3 (en) Small Streptococcus pyogenes antigens and their use
JP2013531993A5 (cg-RX-API-DMAC7.html)
JP2016504993A5 (cg-RX-API-DMAC7.html)
JP2018512124A5 (cg-RX-API-DMAC7.html)
DK2193803T3 (da) Nukleinsyrer, der koder for immunoglobiner, som bærer gp100 og TRP2-epitoper